The Laxmi Dental IPO has witnessed an overwhelming response as it entered the second day of its subscription on January 14, 2025.
With investors showing significant enthusiasm, the IPO has already been subscribed 4.48 times by the end of Day 2, with strong participation across multiple investor categories.
The retail individual investor (RII) category led the way, being subscribed a remarkable 11.43 times. This indicates heightened interest and confidence from small investors.
Non-institutional investors (NII) followed closely with 8.57 times subscription. However, the qualified institutional buyer (QIB) category lagged slightly, recording a subscription of 0.13 times.
In the grey market, Laxmi Dental shares have seen a notable jump in their premium. On January 13, 2025, the grey market premium (GMP) stood at ₹150, implying an estimated listing price of ₹578.
This is a significant 35.05% premium over the issue price of ₹428, showcasing strong market optimism around the IPO.
Laxmi Dental is a leading player in the dental products and equipment manufacturing industry.
With this IPO, the company aims to raise funds to fuel its growth plans, including capacity expansion, debt reduction, and strengthening its research and development capabilities.
The soaring grey market premium and the enthusiastic subscription levels underscore the strong investor sentiment toward the IPO.
However, experts caution that GMP values are unofficial and subject to market fluctuations, and they advise investors to make informed decisions.
The subscription trend and grey market buzz indicate a promising start for Laxmi Dental as it prepares for its listing.
All eyes are now on how the company’s shares perform post-listing on January 20, 2025.
Also Read
Angel One Reports Mixed Q3FY25 Results: Net Profit Up 8% YoY to ₹281 Crore
In a move that is already making waves across the healthcare and political landscape, US…
Logistics is the backbone of Africa’s economic growth. In 2025, as trade flows expand under…
CSL Limited (ASX: CSL), one of Australia’s leading biotechnology firms, has seen its share price…
U.S. President Donald Trump has announced a 100% tariff on imported branded and patented pharmaceutical…
U.S. equities dipped today, reflecting investor caution as the latest economic data complicates the Federal…
Iron Hill Brewery & Restaurant, a beloved chain known for its craft beers and casual…